Dhanvantri Jeevan Rekha

Dhanvantri Jeevan Rekha Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Dhanvantri Jeevan Rekha (531043.BO) as of Nov 1, 2026 is 2.25. In the previous year, Net Debt to Free Cash Flow Ratio was -1.36 — a change of -265.39% (higher).

Net Debt/FCF

2.25

YoY

-265.39%

Last updated:

Net Debt to Free Cash Flow Ratio of Dhanvantri Jeevan Rekha is 2025 2.25 . Net Debt to Free Cash Flow Ratio of Dhanvantri Jeevan Rekha was 2024 -1.36 . It decreases by -265.39% higher compared to the previous year.

The Dhanvantri Jeevan Rekha Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2018
-3.91 INR
Jan 1, 2019
0.11 INR
Jan 1, 2020
0.09 INR
Jan 1, 2021
-0.17 INR
Jan 1, 2022
0.00 INR
Jan 1, 2023
0.83 INR
Jan 1, 2024
-1.36 INR
Jan 1, 2025
2.25 INR
The Dhanvantri Jeevan Rekha Net Debt/FCF history
YEARNet Debt/FCFYoY
2.25-265.39%
-1.36-264.75%
0.83—
0.00-100.00%
-0.17-290.93%
0.09-19.64%
0.11-102.76%
-3.91+99.16%
-1.97-71.46%
-6.89+410.76%
-1.35-1,482.39%
0.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dhanvantri Jeevan Rekha Stock analysis

What does Dhanvantri Jeevan Rekha do? Dhanvantri Jeevan Rekha Ltd. provides healthcare services through Dhanvantri Hospital in Meerut, Uttar Pradesh, offering medical and health-care services to the public. The company specializes in super specialty services including cardiology, gastroenterology, neurology, urology, and diagnostic services. Cardiology services feature an intensive coronary care unit and diagnostic facilities such as echo cardiography, color-doppler, transesophageal echocardiography, stress echo cardiography, carotid and peripheral doppler, treadmill testing (TMT), and Holter monitoring. Neurology services provide intensive management for conditions like stroke, status epilepticus, peripheral nerve and muscle diseases requiring ventilator support, and comatose patient care. The company targets public patients seeking advanced medical care in Meerut, focusing on high-class patient care with specialized services. Dhanvantri Hospital serves as the primary unit delivering these services, emphasizing comprehensive care in cardiology, neurology, and other super specialties. Patients requiring specialized treatments such as coronary care, stroke management, and ventilator-supported neurological care are the key segments served by the company. Dhanvantri Jeevan Rekha Ltd. generates revenue through the provision of medical and health-care services, particularly from its super specialty departments. The hospital unit provides diagnostic services and specialized treatments, including intensive care units and advanced diagnostic equipment, which are billed directly to patients or through insurance channels. Revenue streams are derived from patient consultations, diagnostic procedures, and specialized treatments offered at Dhanvantri Hospital. Dhanvantri Jeevan Rekha is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dhanvantri Jeevan Rekha stock

Net Debt to Free Cash Flow Ratio of Dhanvantri Jeevan Rekha is 2.25 in 2025.

Net Debt to Free Cash Flow Ratio of Dhanvantri Jeevan Rekha changed from -1.36 to 2.25, representing a -265.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Dhanvantri Jeevan Rekha since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Dhanvantri Jeevan Rekha with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Dhanvantri Jeevan Rekha

All Key Metrics — Dhanvantri Jeevan Rekha